Repository logo
 
Publication

2016 Update of the Portuguese Recommendations for the Use of Biological Therapies in Children and Adolescents with Juvenile Idiopathic Arthritis

2016Journal article Open access
Simple item page
dc.contributor.authorSantos, MJ
dc.contributor.authorConde, M
dc.contributor.authorMourão, AF
dc.contributor.authorRamos, FO
dc.contributor.authorCabral, M
dc.contributor.authorBrito, I
dc.contributor.authorRamos, MP
dc.contributor.authorMarques, RC
dc.contributor.authorGomes, SM
dc.contributor.authorGuedes, M
dc.contributor.authorGonçalves, MJ
dc.contributor.authorEstanqueiro, P
dc.contributor.authorZilhão, C
dc.contributor.authorRodrigues, M
dc.contributor.authorHenriques, C
dc.contributor.authorSalgado, M
dc.contributor.authorCanhão, H
dc.contributor.authorFonseca, JE
dc.contributor.authorGomes, JM
dc.date.accessioned2017-03-30T12:08:03Z
dc.date.available2017-03-30T12:08:03Z
dc.date.issued2016
dc.description.abstractTo provide evidence-based guidance for the rational and safe prescription of biological therapies in children and adolescents with juvenile idiopathic arthritis (JIAs) considering the latest available evidence and the new licensed biologics. Rheumatologists and Pediatricians with expertise in Pediatric Rheumatology updated the recommendations endorsed by the Portuguese Society of Rheumatology and the Portuguese Society of Pediatrics based on published evidence and expert opinion. The level of agreement with final propositions was voted using an online survey. RESULTS: In total, 20 recommendations to guide the use of biological therapy in children and adolescents with JIAs are issued, comprising 4 general principles and 16 specific recommendations. A consensus was achieved regarding the eligibility and response criteria, maintenance of biological therapy, and procedures in case of non-response, for each JIA category. Specific recommendations concerning safety procedures were also updated. These recommendations take into account the specificities of each JIA category and are intended to continuously improve the management of JIA patients.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationActa Reumatol Port. 2016;41:194-212pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/2657
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSociedade Portuguesa de Reumatologiapt_PT
dc.subjectJuvenile Idiopathic Arthritispt_PT
dc.subjectBiological Agentspt_PT
dc.subjectChildpt_PT
dc.subjectAdolescentpt_PT
dc.subjectHDE REUM PEDpt_PT
dc.title2016 Update of the Portuguese Recommendations for the Use of Biological Therapies in Children and Adolescents with Juvenile Idiopathic Arthritispt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage212pt_PT
oaire.citation.issue3pt_PT
oaire.citation.startPage194pt_PT
oaire.citation.volume41pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Acta Reumatol Port 2016_41_194.pdf
Size:
439.72 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

REUM PED - Artigos